JSC Grindeks will submit for registration Mildronate injections and capsules in People's Republic of China

During the visit to the People's Republic of China, management of the JSC
Grindeks signed a significant for the company contract about the medicines
registration in China. 
There have been held many important meetings with various Chinese
pharmaceutical manufacturers and an agreement on the registration of Grindeks
originator product Mildronate-injection forms and capsules in the People's
Republic of China was concluded, thus making it possible to sell Mildronate in
China, taking into consideration the huge potential of this Asian country. 
Chairman of the Board, Jānis Romanovskis admits that this visit has been very
successful, allowing concluding important agreement that would make possible
the company to export its production to the vast and persistently growing
market of China. 


Information was prepared by the:
Communications department of JSC Grindeks 
Office: 7083241
E-mail: grindeks@grindeks.lv